Transatlantic differences in the use and outcome of minimally invasive pancreatoduodenectomy: an international multi-registry analysis: an international multi-registry analysis
Uloženo v:
| Název: | Transatlantic differences in the use and outcome of minimally invasive pancreatoduodenectomy: an international multi-registry analysis: an international multi-registry analysis |
|---|---|
| Autoři: | de Graaf, Nine, Augustinus, Simone, Wellner, Ulrich F., Johansen, Karin, Andersson, Bodil, Beane, Joal D., Björnsson, Bergthor, Busch, Olivier R., Davis, Catherine H., Ghadimi, Michael, Gleeson, Elizabeth M., Groot Koerkamp, Bas, Hogg, Melissa E., van Santvoort, Hjalmar C., Tingstedt, Bobby, Uhl, Waldemar, Werner, Jens, Williamsson, Caroline, Zeh, Herbert J., Zureikat, Amer H., Abu Hilal, Mohammad, Pitt, Henry A., Besselink, Marc G., Keck, Tobias, for the Global Audits on Pancreatic Surgery Group (GAPASURG) |
| Přispěvatelé: | MS HOD, Cancer, de Graaf, Nine, Augustinus, Simone, Wellner, Ulrich F., Johansen, Karin, Andersson, Bodil, Beane, Joal D., Björnsson, Bergthor, Busch, Olivier R., Davis, Catherine H., Ghadimi, Michael, Keck, Tobias, for the Global Audits on Pancreatic Surgery Group (GAPASURG) |
| Zdroj: | Surg Endosc |
| Informace o vydavateli: | Springer Science and Business Media LLC, 2024. |
| Rok vydání: | 2024 |
| Témata: | Male, Minimally invasive surgery, pancreatoduodenectomy, Whipple, Pancreatic cancer, Robotic, Robot-assisted, Laparoscopy, Article, Pancreaticoduodenectomy, Postoperative Complications, Robotic Surgical Procedures, Germany, Humans, Registries, Aged, Netherlands, Sweden, Kirurgi, Patient Selection, Middle Aged, Treatment Outcome, North America, Surgery, Female, Pancreaticoduodenectomy/statistics, Aged [MeSH], Patient Selection [MeSH], Postoperative Complications/epidemiology [MeSH], Male [MeSH], Robotic Surgical Procedures/methods [MeSH], Female [MeSH], Laparoscopy/methods [MeSH], Humans [MeSH], Sweden [MeSH], Treatment Outcome [MeSH], North America [MeSH], Middle Aged [MeSH], Laparoscopy/statistics, Pancreaticoduodenectomy/methods [MeSH], Germany [MeSH], Robotic Surgical Procedures/statistics, Netherlands [MeSH], Registries [MeSH] |
| Popis: | Background Minimally invasive pancreatoduodenectomy (MIPD) has emerged as an alternative to open pancreatoduodenectomy (OPD). However, the extent of variation in the use and outcomes of MIPD in relation to OPD among countries is unclear as international studies using registry data are lacking. This study aimed to investigate the use, patient selection, and outcomes of MIPD and OPD in four transatlantic audits for pancreatic surgery. Methods A post hoc comparative analysis including consecutive patients after MIPD and OPD from four nationwide and multicenter pancreatic surgery audits from North America, Germany, the Netherlands, and Sweden (2014–2020). Patient factors related to MIPD were identified using multivariable logistic regression. Outcome analyses excluded the Swedish audit because Results Overall, 44,076 patients who underwent pancreatoduodenectomy were included (29,107 North America, 7586 Germany, 4970 the Netherlands, and 2413 Sweden), including 3328 MIPD procedures (8%). The use of MIPD varied widely among countries (absolute largest difference [ALD] 17%, p p p = 0.297). Patient factors predicting the use of MIPD included country, later year of operation, better performance status, high POPF-risk score, no vascular resection, and non-malignant indication. Conversion rates were higher in laparoscopic MIPD (range 28–45%), compared to robotic MIPD (range 9–37%). In-hospital/30-day mortality differed among North America, Germany, and the Netherlands; MIPD (2%, 7%, 4%; ALD 5%, p p p p Conclusions Considerable differences were found in the use and outcome, including conversion and mortality rates, of MIPD and OPD among four transatlantic audits for pancreatic surgery. Our findings highlight the need for international collaboration to optimize treatment standards and patient outcome. |
| Druh dokumentu: | Article Other literature type |
| Popis souboru: | application/pdf |
| Jazyk: | English |
| ISSN: | 1432-2218 0930-2794 |
| DOI: | 10.1007/s00464-024-11161-7 |
| Přístupová URL adresa: | https://pubmed.ncbi.nlm.nih.gov/39342074 https://pure.eur.nl/en/publications/85bd080b-9541-4eed-86dc-f678f9b66169 https://doi.org/10.1007/s00464-024-11161-7 https://dspace.library.uu.nl/handle/1874/458482 https://pure.amsterdamumc.nl/en/publications/87ba78cd-afd0-479d-b4d3-58e69a0c9191 https://doi.org/10.1007/s00464-024-11161-7 https://resolver.sub.uni-goettingen.de/purl?gro-2/145611 https://repository.publisso.de/resource/frl:6501150 http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-208683 |
| Rights: | CC BY |
| Přístupové číslo: | edsair.doi.dedup.....78e87c87229965c3c477cc9c6c5cc89c |
| Databáze: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstrakt: | Background Minimally invasive pancreatoduodenectomy (MIPD) has emerged as an alternative to open pancreatoduodenectomy (OPD). However, the extent of variation in the use and outcomes of MIPD in relation to OPD among countries is unclear as international studies using registry data are lacking. This study aimed to investigate the use, patient selection, and outcomes of MIPD and OPD in four transatlantic audits for pancreatic surgery. Methods A post hoc comparative analysis including consecutive patients after MIPD and OPD from four nationwide and multicenter pancreatic surgery audits from North America, Germany, the Netherlands, and Sweden (2014–2020). Patient factors related to MIPD were identified using multivariable logistic regression. Outcome analyses excluded the Swedish audit because Results Overall, 44,076 patients who underwent pancreatoduodenectomy were included (29,107 North America, 7586 Germany, 4970 the Netherlands, and 2413 Sweden), including 3328 MIPD procedures (8%). The use of MIPD varied widely among countries (absolute largest difference [ALD] 17%, p p p = 0.297). Patient factors predicting the use of MIPD included country, later year of operation, better performance status, high POPF-risk score, no vascular resection, and non-malignant indication. Conversion rates were higher in laparoscopic MIPD (range 28–45%), compared to robotic MIPD (range 9–37%). In-hospital/30-day mortality differed among North America, Germany, and the Netherlands; MIPD (2%, 7%, 4%; ALD 5%, p p p p Conclusions Considerable differences were found in the use and outcome, including conversion and mortality rates, of MIPD and OPD among four transatlantic audits for pancreatic surgery. Our findings highlight the need for international collaboration to optimize treatment standards and patient outcome. |
|---|---|
| ISSN: | 14322218 09302794 |
| DOI: | 10.1007/s00464-024-11161-7 |